drugset / Trial / NCT04274361

Ketamine for Pain Control After Severe Traumatic Injury

NCT04274361 ↗

Completed 93 enrolled Medical College of Wisconsin
RandomizedParallel-groupOpen-labelTreatment

Summary

This study evaluates if the early utilization of ketamine infusion therapy among acutely injured adult trauma hospital inpatients with an ISS \>15 will decrease the amount of opioid pain medication used as compared with placebo group. Ketamine infusion therapy initiated within 12 hours of hospital arrival will lead to decreased total opiate consumption (standardized to oral morphine equivalent units) in the first 24 and 48 hours compared to controls.

Timeline

Start
2021-01-20
Primary completion
2025-02-28
Completion
2025-02-28

Outcome

Missed primary endpoint

paper Adjustable dose ketamine failed to reduce OME totals or pain scores in a severely injured trauma cohort when compared with placebo at any time point. PMID 40152587 ↗

Drugs

EvaluationDrugModalityDoseRoute
Subject Ketamine Small molecule 3 ug/kg —

Indications